- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical trials of immunotherapy in triple-negative breast cancer ; volume:195 ; number:1 ; day:14 ; month:7 ; year:2022 ; pages:1-15 ; date:8.2022
Breast cancer research and treatment ; 195, Heft 1 (14.7.2022), 1-15, 8.2022
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-022-06665-6
- URN
-
urn:nbn:de:101:1-2022101517344652538312
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Howard, Frederick
- Pearson, Alexander T.
- Nanda, Rita
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Characterization of immunomodulating agents from Staphylococcus aureus for priming immunotherapy in triple-negative breast cancers
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Characterization of immunomodulating agents from Staphylococcus aureus for priming immunotherapy in triple-negative breast cancers
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer